Anke Wixmerten

671 total citations
15 papers, 485 citations indexed

About

Anke Wixmerten is a scholar working on Surgery, Rheumatology and Urology. According to data from OpenAlex, Anke Wixmerten has authored 15 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Rheumatology and 5 papers in Urology. Recurrent topics in Anke Wixmerten's work include Osteoarthritis Treatment and Mechanisms (7 papers), Periodontal Regeneration and Treatments (5 papers) and Knee injuries and reconstruction techniques (4 papers). Anke Wixmerten is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Periodontal Regeneration and Treatments (5 papers) and Knee injuries and reconstruction techniques (4 papers). Anke Wixmerten collaborates with scholars based in Switzerland, Germany and Italy. Anke Wixmerten's co-authors include Iván Martín, Sylvie Miot, Andrea Barbero, Dirk J. Schaefer, Martin Haug, Marcel Jakob, Françine Wolf, Sandra Feliciano, M. Adelaide Asnaghi and Karoliina Pelttari and has published in prestigious journals such as The Lancet, Biosensors and Bioelectronics and Biochemical Society Transactions.

In The Last Decade

Anke Wixmerten

14 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anke Wixmerten Switzerland	9	272	245	137	135	111	15	485
Sandra Feliciano Switzerland	8	332 1.2×	293 1.2×	132 1.0×	158 1.2×	146 1.3×	12	561
Mami Kokubo Japan	12	304 1.1×	309 1.3×	116 0.8×	182 1.3×	109 1.0×	16	598
Quanyi Guo China	5	176 0.6×	233 1.0×	136 1.0×	203 1.5×	76 0.7×	8	453
Christopher R. Rowland United States	6	308 1.1×	281 1.1×	194 1.4×	237 1.8×	112 1.0×	10	589
Toshiharu Kutsuna Japan	9	257 0.9×	197 0.8×	80 0.6×	125 0.9×	96 0.9×	12	393
G.J. van Osch Netherlands	6	379 1.4×	199 0.8×	118 0.9×	70 0.5×	144 1.3×	12	566
Genya Mitani Japan	14	383 1.4×	379 1.5×	172 1.3×	220 1.6×	128 1.2×	31	718
Olivier Démarteau Switzerland	7	420 1.5×	263 1.1×	133 1.0×	164 1.2×	147 1.3×	9	565
Elizabeth Lowder United States	10	169 0.6×	205 0.8×	105 0.8×	108 0.8×	82 0.7×	15	423
Cheng‐Hung Chou Taiwan	12	195 0.7×	118 0.5×	145 1.1×	159 1.2×	131 1.2×	17	507

Countries citing papers authored by Anke Wixmerten

Since Specialization

Citations

This map shows the geographic impact of Anke Wixmerten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Wixmerten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Wixmerten more than expected).

Fields of papers citing papers by Anke Wixmerten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Wixmerten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Wixmerten. The network helps show where Anke Wixmerten may publish in the future.

Co-authorship network of co-authors of Anke Wixmerten

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Wixmerten. A scholar is included among the top collaborators of Anke Wixmerten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Wixmerten. Anke Wixmerten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wixmerten, Anke, Corina Schuster‐Amft, Sylvie Miot, et al.. (2025). Treatment of patellofemoral osteoarthritis with nasal chondrocyte-based engineered cartilage implantation in a randomised, controlled, multicentre phase II clinical trial: protocol for a randomised controlled trial. BMJ Open. 15(8). e106140–e106140.

Miot, Sylvie, Anke Wixmerten, Oliver Pullig, et al.. (2024). Engineered autologous nasal cartilage for repair of nasal septal perforations: a case series. International Journal of Surgery. 110(10). 6573–6580. 2 indexed citations

Wixmerten, Anke, Sylvie Miot, Françine Wolf, et al.. (2023). Good Manufacturing Practice–compliant change of raw material in the manufacturing process of a clinically used advanced therapy medicinal product–a comparability study. Cytotherapy. 25(5). 548–558. 7 indexed citations

Lunger, Alexander, Rik Osinga, Franziska Saxer, et al.. (2021). Case Report: Reconstruction of a Large Maxillary Defect With an Engineered, Vascularized, Prefabricated Bone Graft. Frontiers in Oncology. 11. 775136–775136. 9 indexed citations

Schwarz, Thomas, Robert Schmitt, Ulrich Blache, et al.. (2021). From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product. Frontiers in Medicine. 8. 712917–712917. 10 indexed citations

Power, Laura, Claudia Fasolato, Andrea Barbero, et al.. (2020). Sensing tissue engineered cartilage quality with Raman spectroscopy and statistical learning for the development of advanced characterization assays. Biosensors and Bioelectronics. 166. 112467–112467. 10 indexed citations

Mumme, Marcus, Anke Wixmerten, Sylvie Miot, et al.. (2019). Tissue engineering for paediatric patients. Swiss Medical Weekly. 149(1314). w20032–w20032. 9 indexed citations

Power, Laura, Anke Wixmerten, David Wendt, Andrea Barbero, & Iván Martín. (2019). Raman spectroscopy quality controls for GMP compliant manufacturing of tissue engineered cartilage. 14–14. 3 indexed citations

Mumme, Marcus, Andrea Barbero, Sylvie Miot, et al.. (2016). Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial. The Lancet. 388(10055). 1985–1994. 189 indexed citations

10.

Fulco, Ilario, Sylvie Miot, Martin Haug, et al.. (2014). Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial. The Lancet. 384(9940). 337–346. 136 indexed citations

11.

Fulco, Ilario, René D. Largo, Sylvie Miot, et al.. (2013). Toward Clinical Application of Tissue-Engineered Cartilage. Facial Plastic Surgery. 29(2). 99–105. 10 indexed citations

12.

Miot, Sylvie, Walter Brehm, Sally C. Dickinson, et al.. (2012). Influence of in vitro maturation of engineered cartilage on the outcome of osteochondral repair in a goat model. European Cells and Materials. 23. 222–246. 63 indexed citations

13.

Pelttari, Karoliina & Anke Wixmerten. (2009). Do we really need cartilage tissue engineering?. Swiss Medical Weekly. 139(4142). 602–602. 28 indexed citations

14.

Beier, M., Matthias Scheffler, Anke Wixmerten, et al.. (2003). Geniom® Technology—The Benchtop Array Facility. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1721–1723. 6 indexed citations

15.

Beier, M., et al.. (2002). Exploring Nature's plasticity with a flexible probing tool, and finding new ways for its electronic distribution. Biochemical Society Transactions. 30(2). 78–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact